What is Meditrend?
Meditrend, Inc. is a notable entity within the health and wellness industry, specializing in the development and distribution of allergy relief and nutritional support products. Its core product lines, Allergena and Progena, target consumers seeking natural solutions for allergies and general health improvement, including immune and cardiovascular support. The company's commitment to high-quality, natural products positions it to cater to a broad consumer base, from adults to children, looking for effective health management alternatives.
How much funding has Meditrend raised?
Meditrend has raised a total of $123K across 1 funding round:
Debt
$123K
Debt (2021): $123K with participation from PPP
What's next for Meditrend?
The substantial backing indicated by $123K suggests Meditrend is in a mature growth phase, likely leveraging this capital for market expansion, product innovation, and potentially strategic acquisitions. The recent strategic investment signals strong confidence from financial partners in Meditrend's business model and future prospects, paving the way for enhanced market penetration and the introduction of new health solutions.
See full Meditrend company page
